首页> 美国卫生研究院文献>Journal of Neurological Surgery. Part B Skull Base >Outcomes of Temporal Bone Resection for Locally Advanced Parotid Cancer
【2h】

Outcomes of Temporal Bone Resection for Locally Advanced Parotid Cancer

机译:局部晚期腮腺癌颞骨切除的结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study was conducted to report outcomes and identify factors predictive of survival and recurrence in patients undergoing lateral temporal bone resection (LTBR) as part of an extended radical parotidectomy for parotid cancer. This is a retrospective cohort study which includes all patients undergoing LTBR for parotid cancer between 1994 and 2010 at two affiliated academic centers. Survival and recurrence rates were analyzed using the Kaplan-Meier method and Cox multivariate regression. A total of 12 patients with median follow-up duration of 30.6 months were included: 6 de novo cases and 6 patients referred after local recurrence. Actuarial locoregional control at 2 years was 73%. Most patients (11; 92%) developed disease recurrence with distant metastases the most common site of first failure (83%). Overall and disease-specific survival rates were 80% at 2 years and 22.5% at 5 years. Recurrence-free survival (RFS) was 67% at 2 years and 8.3% at 5 years. On multivariate analysis, surgical margin status was an independent predictor of RFS (hazard ratio = 3.85, p = 0.045). In advanced parotid cancer, LTBR with a goal of gross total resection offers good locoregional control with an acceptable complication rate. The benefits of this surgery must be balanced with the morbidity and low likelihood of long-term survival, with most patients ultimately experiencing disease recurrence and death.
机译:这项研究的目的是报告结局,并确定进行颞颞骨切除术(LTBR)的患者的生存和复发的预测因素,该患者是腮腺癌根治性扩大腮腺切除术的一部分。这是一项回顾性队列研究,其中包括1994年至2010年之间在两个附属学术中心接受LTBR治疗腮腺癌的所有患者。使用Kaplan-Meier方法和Cox多元回归分析生存率和复发率。总共包括12例患者,中位随访时间为30.6个月:6例从头病例和6例在局部复发后转诊。 2年时精算局部控制为73%。大多数患者(11; 92%)发生疾病复发,且远处转移是首次失败的最常见部位(83%)。总体生存率和疾病特异性生存率在2年时为80%,在5年时为22.5%。无复发生存期(RFS)在2年时为67%,在5年时为8.3%。在多变量分析中,手术切缘状态是RFS的独立预测指标(危险比= 3.85,p = 0.045)。在晚期腮腺癌中,以全切除为目标的LTBR可提供良好的局部区域控制,并具有可接受的并发症发生率。该手术的好处必须与发病率和长期生存的可能性低相平衡,大多数患者最终都会出现疾病复发和死亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号